90 results
8-K
EX-99.1
ANIX
Anixa Biosciences Inc
8 May 24
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
8:35am
this new JDA will be led at Cleveland Clinic by Thaddeus Stappenbeck, MD, PhD, Department Chair of Inflammation and Immunity, and will include Justin
S-8
ANIX
Anixa Biosciences Inc
16 Jan 24
Registration of securities for employees
4:43pm
. Department of Defense grant to Cleveland Clinic, is a multiple-ascending dose Phase 1 trial to determine the maximum tolerated dose (“MTD”) of the vaccine
8-K
EX-99.1
ANIX
Anixa Biosciences Inc
7 Dec 23
Regulation FD Disclosure
6:01am
from the U.S. Department of Defense.
The data were presented at the 2023 San Antonio Breast Cancer Symposium by G. Thomas Budd, M.D., staff … breast cancer vaccine technology invented at Cleveland Clinic, the site of the Phase 1 trial. The grant from the U.S. Department of Defense was made
8-K
EX-99.1
vrmloogybu1na6uzgzo7
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
8-K
27rs465
29 Sep 22
Regulation FD Disclosure
8:30am
S-8
s1vil19d
4 Jan 22
Registration of securities for employees
4:12pm
8-K
ugg1fo hrtna5
28 Oct 21
Regulation FD Disclosure
4:54pm
8-K
l350q
4 Oct 21
Other Events
7:00am
8-K
EX-1.1
qm4sj4fcb3 8nmh
24 Mar 21
Entry into a Material Definitive Agreement
4:28pm